Loxo Oncology, Inc. (NASDAQ: LOXO)

Rowley Law PLLC is investigating potential claims against Loxo Oncology, Inc. (NASDAQ: LOXO) and its board of directors for breach of fiduciary duty concerning the proposed acquisition of the company by Eli Lilly and Company (NYSE: LLY). Stockholders will receive $235.00 for each share of Loxo Oncology, Inc. stock that they hold. The transaction is valued at approximately $8 billion and is expected to close by the end of the first quarter of 2019.

If you are a Loxo Oncology, Inc. stockholder and are interested in obtaining additional information regarding this investigation, please fill in the contact form on this page. You may also contact Shane Rowley, Esq. at Rowley Law PLLC, 50 Main Street Suite 1000, White Plains, NY 10606, by email at info@rowleylawpllc.com, or by telephone at 914-400-1920 or 844-400-4643 (toll-free).

Rowley Law PLLC represents shareholders nationwide in class actions and derivative lawsuits in complex corporate litigation.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Request Information

The submission of this form does not create an attorney-client relationship.